BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24727322)

  • 61. [(18)F]FDG is not transported by P-glycoprotein and breast cancer resistance protein at the rodent blood-brain barrier.
    Wanek T; Traxl A; Bankstahl JP; Bankstahl M; Sauberer M; Langer O; Kuntner C
    Nucl Med Biol; 2015 Jul; 42(7):585-9. PubMed ID: 25823393
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites.
    F Martins ML; Heydari P; Li W; Martínez-Chávez A; Venekamp N; Lebre MC; Lucas L; Beijnen JH; Schinkel AH
    Front Pharmacol; 2022; 13():855000. PubMed ID: 35308219
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of levosulpiride in healthy subjects.
    Cho HY; Yoo HD; Lee YB
    Neuroscience; 2010 Aug; 169(1):378-87. PubMed ID: 20438811
    [TBL] [Abstract][Full Text] [Related]  

  • 64. P-glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Main Active Heroin Metabolites 6-monoacetylmorphine (6-MAM) and Morphine in Mice.
    F Martins ML; Loos NHC; El Yattouti M; Offeringa L; Heydari P; Hillebrand MJX; Lebre MC; Beijnen JH; Schinkel AH
    Pharm Res; 2023 Aug; 40(8):1885-1899. PubMed ID: 37344602
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models.
    Lin F; de Gooijer MC; Hanekamp D; Chandrasekaran G; Buil LC; Thota N; Sparidans RW; Beijnen JH; Würdinger T; van Tellingen O
    Clin Cancer Res; 2017 Mar; 23(5):1286-1298. PubMed ID: 27553832
    [No Abstract]   [Full Text] [Related]  

  • 66. Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [
    Hernández Lozano I; Bauer M; Wulkersdorfer B; Traxl A; Philippe C; Weber M; Häusler S; Stieger B; Jäger W; Mairinger S; Wanek T; Hacker M; Zeitlinger M; Langer O
    Mol Pharm; 2020 Jan; 17(1):316-326. PubMed ID: 31790256
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
    [TBL] [Abstract][Full Text] [Related]  

  • 68. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
    Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rifampin and ritonavir increase oral availability and elacridar enhances overall exposure and brain accumulation of the NTRK inhibitor larotrectinib.
    Wang Y; Sparidans RW; Wang J; Li W; Lebre MC; Beijnen JH; Schinkel AH
    Eur J Pharm Biopharm; 2022 Jan; 170():197-207. PubMed ID: 34952136
    [TBL] [Abstract][Full Text] [Related]  

  • 70. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice.
    Spiro AS; Wong A; Boucher AA; Arnold JC
    PLoS One; 2012; 7(4):e35937. PubMed ID: 22536451
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coadministration of ABCB1/P-glycoprotein inhibitor elacridar improves tissue distribution of ritonavir-boosted oral cabazitaxel in mice.
    Loos NHC; Martins MLF; de Jong D; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
    Int J Pharm; 2024 Jan; 650():123708. PubMed ID: 38135258
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors.
    de Gooijer MC; Zhang P; Weijer R; Buil LCM; Beijnen JH; van Tellingen O
    Int J Cancer; 2018 Jan; 142(2):381-391. PubMed ID: 28921565
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain.
    Strope JD; Peer CJ; Sissung TM; Hall OM; Huang PA; Harris EM; Gustafson KR; Henrich CJ; Sigano DM; Pauly GT; Schneider JP; Bates SE; Figg WD
    Cancer Biol Ther; 2020; 21(3):223-230. PubMed ID: 31709896
    [No Abstract]   [Full Text] [Related]  

  • 75. Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [
    Traxl A; Mairinger S; Filip T; Sauberer M; Stanek J; Poschner S; Jäger W; Zoufal V; Novarino G; Tournier N; Bauer M; Wanek T; Langer O
    Mol Pharm; 2019 Mar; 16(3):1282-1293. PubMed ID: 30694684
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice.
    Shukla S; Zaher H; Hartz A; Bauer B; Ware JA; Ambudkar SV
    Pharm Res; 2009 Feb; 26(2):480-7. PubMed ID: 18841445
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors.
    Zhang P; de Gooijer MC; Buil LC; Beijnen JH; Li G; van Tellingen O
    Int J Cancer; 2015 Oct; 137(8):2007-18. PubMed ID: 25868794
    [TBL] [Abstract][Full Text] [Related]  

  • 78. P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib.
    de Gooijer MC; Zhang P; Thota N; Mayayo-Peralta I; Buil LC; Beijnen JH; van Tellingen O
    Invest New Drugs; 2015 Oct; 33(5):1012-9. PubMed ID: 26123925
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Abcb1a and Abcb1b expression in senescence-accelerated mouse (SAM).
    Wu B; Ueno M; Kusaka T; Onodera M; Huang CL; Hosomi N; Kanenishi K; Sakamoto H
    Neurosci Lett; 2009 May; 456(1):34-8. PubMed ID: 19429129
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Abcb1a but not Abcg2 played a predominant role in limiting the brain distribution of Huperzine A in mice.
    Li J; Yue M; Zhou D; Wang M; Zhang H
    Food Chem Toxicol; 2017 Sep; 107(Pt A):68-73. PubMed ID: 28587984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.